HappeningToo topic
Adalimumab-aaty reports
Browse community reports connected to Adalimumab-aaty. These reports can show that other people are describing similar experiences, but they do not prove that Adalimumab-aaty caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
25 problems
Abdominal Discomfort while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and abdominal discomfort appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and abdominal pain upper appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and abdominal pain appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and alopecia appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and decreased appetite appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and diarrhea appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and dizziness appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and dry mouth appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and dyspepsia appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and fatigue appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and headache appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and hives appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and insomnia appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and itching appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and malaise appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and nausea appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and pain appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and rash appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and shortness of breath appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and sleep disorder appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and swelling appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and vomiting appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and weakness appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and weight decreased appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Adalimumab-aaty
FDA FAERS contains adverse-event reports in which Adalimumab-aaty and weight increased appear together. This does not establish that Adalimumab-aaty caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →